You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Oxford Vaccine Shows Promising Results as New Data Suggests Antibodies in Recovered Cases Don’t Last

HeadlineOct 27, 2020

In medical news, scientists at AstraZeneca said Monday an experimental vaccine being developed at Oxford University in Britain has shown promising results as the vaccine has triggered an immune response in both younger and older patients. Meanwhile, researchers at Imperial College in London found the number of people testing positive for COVID-19 antibodies has fallen by 26% between June and September, suggesting immunity fades rapidly and people who have recovered can be reinfected.

In more medical news, drug maker Eli Lilly said Monday its antibody treatment was ineffective on hospitalized patients with advanced cases and that a government-sponsored trial would stop administering the drug to new patients.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top